Literature DB >> 21143239

Adaptive T-cell responses regulating oral tolerance to protein antigen.

M F du Pré1, J N Samsom.   

Abstract

The term oral (or mucosal) tolerance has been classically defined as the suppression of T- and B-cell responses to an antigen by prior administration of the antigen by the oral route. In recent years, it has become clear that both innate and acquired regulatory immune responses are essential for the development of oral tolerance. As such, mucosal microenvironmental factors such as transforming growth factor- β, prostaglandins but also dietary vitamin A create conditioning of an adaptive regulatory T-cell response that suppresses subsequent antigen-specific responses. Particular resident subsets of antigen presenting dendritic cells are pivotal to convey conditioning signals next to the presentation of antigen. This review discusses the primary mechanisms of adaptive regulatory T-cell induction to ingested soluble protein antigen. However, we also discuss the limitations of our knowledge with respect to understanding the very common food hypersensitivity Celiac disease caused by an aberrant adaptive immune response to the food protein gluten.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21143239     DOI: 10.1111/j.1398-9995.2010.02519.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  11 in total

Review 1.  Mechanism of oral tolerance induction to therapeutic proteins.

Authors:  Xiaomei Wang; Alexandra Sherman; Gongxian Liao; Kam W Leong; Henry Daniell; Cox Terhorst; Roland W Herzog
Journal:  Adv Drug Deliv Rev       Date:  2012-11-02       Impact factor: 15.470

Review 2.  Pathophysiology of celiac disease.

Authors:  Sonia S Kupfer; Bana Jabri
Journal:  Gastrointest Endosc Clin N Am       Date:  2012-08-30

3.  Oral immunotherapy for pollen allergy using T-cell epitope-containing egg white derived from genetically manipulated chickens.

Authors:  Yoshinori Kawabe; Yuuki Hayashida; Kensaku Numata; Shota Harada; Yoshifumi Hayashida; Akira Ito; Masamichi Kamihira
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

4.  Development of mucosal immunity in children: a rationale for sublingual immunotherapy?

Authors:  Aleksandra Szczawinska-Poplonyk
Journal:  J Allergy (Cairo)       Date:  2011-10-27

5.  Functional transforming growth factor-β receptor type II expression by CD4+ T cells in Peyer's patches is essential for oral tolerance induction.

Authors:  Rebekah S Gilbert; Ryoki Kobayashi; Shinichi Sekine; Kohtaro Fujihashi
Journal:  PLoS One       Date:  2011-11-07       Impact factor: 3.240

6.  Bifidobacterium breve attenuates murine dextran sodium sulfate-induced colitis and increases regulatory T cell responses.

Authors:  Bin Zheng; Jeroen van Bergenhenegouwen; Saskia Overbeek; Hendrik J G van de Kant; Johan Garssen; Gert Folkerts; Paul Vos; Mary E Morgan; Aletta D Kraneveld
Journal:  PLoS One       Date:  2014-05-02       Impact factor: 3.240

Review 7.  CD69 is the crucial regulator of intestinal inflammation: a new target molecule for IBD treatment?

Authors:  Katarina Radulovic; Jan Hendrik Niess
Journal:  J Immunol Res       Date:  2015-02-22       Impact factor: 4.818

8.  IL-10 Receptor or TGF-β Neutralization Abrogates the Protective Effect of a Specific Nondigestible Oligosaccharide Mixture in Cow-Milk-Allergic Mice.

Authors:  JoAnn Kerperien; Désirée Veening-Griffioen; Tjalling Wehkamp; Betty C A M van Esch; Gerard A Hofman; Paquita Cornelissen; Louis Boon; Prescilla V Jeurink; Johan Garssen; Leon M J Knippels; Linette E M Willemsen
Journal:  J Nutr       Date:  2018-08-01       Impact factor: 4.798

9.  New perspective on dextran sodium sulfate colitis: antigen-specific T cell development during intestinal inflammation.

Authors:  Mary E Morgan; Bin Zheng; Pim J Koelink; Hendrick J G van de Kant; Lizette C J M Haazen; Manon van Roest; Johan Garssen; Gert Folkerts; Aletta D Kraneveld
Journal:  PLoS One       Date:  2013-07-25       Impact factor: 3.240

10.  Colonic tolerance develops in the iliac lymph nodes and can be established independent of CD103(+) dendritic cells.

Authors:  S Veenbergen; L A van Berkel; M F du Pré; J He; J J Karrich; L M M Costes; F Luk; Y Simons-Oosterhuis; H C Raatgeep; V Cerovic; T Cupedo; A M Mowat; B L Kelsall; J N Samsom
Journal:  Mucosal Immunol       Date:  2015-11-18       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.